Growth Metrics

Acadia Healthcare Company (ACHC) Gains from Investment Securities (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Gains from Investment Securities for 16 consecutive years, with $509411.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 486.81% to $509411.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $509411.0, a 486.81% increase, with the full-year FY2025 number at $509411.0, up 486.81% from a year prior.
  • Gains from Investment Securities was $509411.0 for Q4 2025 at Acadia Healthcare Company, up from $168920.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $82.4 million in Q4 2021 to a low of -$7.4 million in Q3 2022.
  • A 5-year average of $4.4 million and a median of $609069.0 in 2024 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: surged 754.51% in 2021, then plummeted 620.08% in 2023.
  • Acadia Healthcare Company's Gains from Investment Securities stood at $82.4 million in 2021, then crashed by 98.81% to $979277.0 in 2022, then tumbled by 620.08% to -$5.1 million in 2023, then surged by 101.7% to $86810.0 in 2024, then soared by 486.81% to $509411.0 in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Gains from Investment Securities are $509411.0 (Q4 2025), $168920.0 (Q3 2025), and $124710.0 (Q2 2025).